In this context, signs of hypothalamic/hippocampal inflammation and motor symptoms severity positively correlate with plasma IL-6 levels, and these IL-6 concentrations negatively correlate with cognitive performance in both AD and PD affected patients [50, 51]. This evidence concerns the gene IL6 and Parkinson disease.